Number of Americans taking GLP-1s for weight loss hits record high: Survey

A record number of Americans are taking GLP-1 drugs for weight loss, according to a new Gallup survey released Tuesday — a massive increase over the past two years. 

According to the poll, 11 percent of Americans currently take a GLP-1 medication for weight loss, compared to just 3 percent in 2024. 

In addition, 15 percent of respondents said they had taken the medicine for weight loss at some point, an increase of 9 percentage points. 

At the same time, the U.S. adult obesity rate has gradually dropped to 36.4 percent thus far in 2026, down from a record-high 39.9 percent in 2022, the year after Wegovy was first approved by the Food and Drug Administration (FDA) to treat weight loss. 

Rates of diabetes diagnoses are also now steady after rising slowly for 15 years, concurrent with rising obesity. 

The analysis is part of the Gallup National Health and Well-Being Index. The results are based on........

© The Hill